Construction of a Database for TTP

Launched by THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY · Oct 5, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on creating a database to better understand Thrombotic Thrombocytopenic Purpura (TTP), a serious blood condition. Researchers at the First Affiliated Hospital of Soochow University will collect information from about 200 patients diagnosed with severe ADAMTS13 deficiency, a specific type of TTP. The study will run from October 20, 2022, to October 20, 2027. By gathering details like age, gender, and clinical information, the researchers hope to improve knowledge and treatment of this condition.

To participate in the study, individuals must have been diagnosed with a severe deficiency in a specific enzyme called ADAMTS13, which means their levels are very low. The trial is currently recruiting participants of all ages and genders. Those who join can expect to provide some basic health information and may be contacted for follow-up, allowing researchers to learn more about TTP and how it affects patients. It’s important to note that anyone who is unable or unwilling to follow the study procedures will not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Subjects diagnosed with severe ADAMTS13 deficiency, defined as ADAMTS13 activity \<10%, documented in the patient's medical history or at screening.
• Exclusion Criteria:
• • - The investigator considers the subject unable or unwilling to cooperate with the study procedures.